News
Hosted on MSN6mon
Response begins enrolment for trial of RDX-002 for weight managementRDX-002 is a potent, selective and gut-specific inhibitor of intestinal microsomal triglyceride transfer protein (iMTP). By inhibiting iMTP, RDX-002 reduces the absorption of triglycerides and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results